| Literature DB >> 27020458 |
Kulthida Methawasin1, Piyanant Chonmaitree1, Chatchawan Wongjitrat1, Suthee Rattanamongkolgul2, Thanin Asawavichienjinda3.
Abstract
OBJECTIVE: The aim of this subgroup analysis was to identify the risk factors associated with the development of various movement disorder phenotypes.Entities:
Keywords: Bradykinesia; Cirrhosis; Hepatic encephalopathy; Intention tremor; Jerky pursuit; Parkinsonism
Year: 2016 PMID: 27020458 PMCID: PMC4886199 DOI: 10.14802/jmd.15047
Source DB: PubMed Journal: J Mov Disord ISSN: 2005-940X
Figure 1.The flow chart illustrates the research process and the numbers of non-Wilsonian cirrhotic patients who presented with each movement disorder phenotype. Intention tremor, bradykinesia, Parkinsonism and abnormal ocular movement groups were included in the subgroup analysis.
The univariate analysis of variables associated with the prevalence of intention tremors (n = 53)
| Variables | Number of cases[ | OR | 95% confidence interval | |
|---|---|---|---|---|
| Gender (male) | 48 | < 0.001[ | 7.34[ | 2.67–20.17[ |
| Hepatitis B virus | 18 | 0.21 | 0.64 | 0.31–1.30 |
| Hepatitis C virus | 8 | 0.37 | 0.66 | 0.26–1.64 |
| Alcoholism | 40 | < 0.001[ | 6.15[ | 2.86–13.21[ |
| NASH | 2 | 0.02[ | 0.18[ | 0.04–0.82[ |
| Cryptogenic | 0 | 0.99 | - | - |
| Combined | 15 | 0.14 | 1.82 | 0.81–4.08 |
| Portal hypertension | 44 | 0.11 | 1.98 | 0.84–4.64 |
| Hepatocellular carcinoma | 10 | 0.28 | 1.67 | 0.65–4.24 |
| Hepatic encephalopathy | 23 | 0.35 | 1.39 | 0.69–2.78 |
| History of alcohol consumption | 42 | < 0.001[ | 4.36[ | 1.99–9.54[ |
| Diabetes mellitus | 20 | 0.69 | 1.15 | 0.57–2.33 |
| Hypertension | 22 | 0.75 | 1.11 | 0.55–2.22 |
| Previous history of stroke | 2 | 0.31 | 3.49 | 0.30–39.44 |
| Renal insufficiency | 2 | 0.89 | 1.13 | 0.18–7.03 |
| Coronary artery disease | 1 | 0.70 | 1.71 | 0.10–27.94 |
| Hyperlipidemia | 21 | 0.18 | 1.61 | 0.79–3.30 |
| Motor and sensory deficit | 3 | 0.47 | 0.60 | 0.15–2.39 |
| Motor or sensory deficit | 8 | 0.76 | 1.15 | 0.43–3.03 |
statistically significant,
one case had more than one variable.
NASH: non-alcoholic steatohepatitis, OR: odds ratio, n: total number of cases.
The univariate analysis of variables associated with the prevalence of bradykinesia (n = 28)
| Variables | Number of cases[ | OR | 95% confidence interval | |
|---|---|---|---|---|
| Gender (female) | 13 | 0.04[ | 2.34[ | 1.00–5.49[ |
| Hepatitis B virus | 9 | 0.31 | 0.63 | 0.26–1.53 |
| Hepatitis C virus | 3 | 0.22 | 0.45 | 0.12–1.63 |
| Alcoholism | 16 | 0.33 | 1.50 | 0.65–3.46 |
| NASH | 4 | 0.76 | 1.20 | 0.36–3.98 |
| Cryptogenic | 1 | 0.31 | 4.22 | 0.25–69.66 |
| Combined cause | 5 | 0.58 | 0.74 | 0.25–2.15 |
| Portal hypertension | 23 | 0.36 | 1.62 | 0.56–4.65 |
| Hepatocellular carcinoma | 4 | 0.94 | 0.96 | 0.29–3.11 |
| Hepatic encephalopathy | 26 | < 0.001[ | 38.55[ | 8.61–172.52 |
| History of alcohol consumption | 19 | 0.27 | 1.62 | 0.67–3.89 |
| Diabetes mellitus | 13 | 0.18 | 1.75 | 0.76–4.06 |
| Hypertension | 12 | 0.71 | 1.16 | 0.50–2.69 |
| Previous history of stroke | 0 | 0.99 | - | - |
| Renal insufficiency | 2 | 0.26 | 2.87 | 0.45–18.07 |
| Coronary artery disease | 2 | 0.99 | - | - |
| Hyperlipidemia | 7 | 0.32 | 0.62 | 0.24–1.59 |
| Motor and sensory deficit | 3 | 0.47 | 1.67 | 0.41–6.77 |
| Motor or sensory deficit | 6 | 0.21 | 1.96 | 0.68–5.68 |
statistically significant,
one case had more than one variable.
NASH: non-alcoholic steatohepatitis, OR: odds ratio, n: total number of cases.
The univariate analysis of variables associated with the prevalence of Parkinsonism (n = 15)
| Variables | Number of cases[ | OR | 95% confidence interval | |
|---|---|---|---|---|
| Gender (male) | 11 | 0.71 | 1.25 | 0.37–4.16 |
| Hepatitis B virus | 6 | 0.96 | 0.97 | 0.32–2.90 |
| Hepatitis C virus | 2 | 0.56 | 0.63 | 0.13–2.99 |
| Alcoholism | 10 | 0.15 | 2.26 | 0.73–7.00 |
| NASH | 0 | 0.99 | - | - |
| Cryptogenic | 0 | 0.99 | - | - |
| Combined cause | 3 | 0.86 | 0.89 | 0.23–3.38 |
| Portal hypertension | 13 | 0.30 | 2.25 | 0.48–10.53 |
| Hepatocellular carcinoma | 3 | 0.54 | 1.52 | 0.39–5.95 |
| Hepatic encephalopathy | 8 | 0.21 | 1.97 | 0.67–5.77 |
| History of alcohol consumption | 11 | 0.23 | 2.07 | 0.62–6.85 |
| Diabetes mellitus | 5 | 0.84 | 0.89 | 0.28–2.76 |
| Hypertension | 4 | 0.27 | 0.51 | 0.15–1.70 |
| Previous history of stroke | 2 | 0.01[ | 19.53[ | 1.65–230.38[ |
| Renal insufficiency | 1 | 0.49 | 2.21 | 0.23–21.21 |
| Coronary artery disease | 0 | 0.99 | - | - |
| Hyperlipidemia | 1 | 0.05 | 0.12 | 0.01–1.00 |
| Motor and sensory deficit | 2 | 0.40 | 2.01 | 0.39–10.35 |
| Motor or sensory deficit | 5 | 0.03[ | 3.76[ | 1.13–12.51[ |
statistically significant,
one case had more than one variable.
NASH: non-alcoholic steatohepatitis, OR: odds ratio, n: total number of cases.
The univariate analysis of variables associated with the prevalence of nystagmus and jerky pursuits (n = 29)
| Variables | Nystagmus ( | Jerky pursuit ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Cases[ | OR | 95% CI | Cases[ | OR | 95% CI | |||
| Gender (male) | 12 | 0.17 | 2.89 | 0.62–13.53 | 14 | 0.06 | 7.08 | 0.90–55.65 |
| Hepatitis B virus | 6 | 0.85 | 1.11 | 0.36–3.38 | 4 | 0.25 | 0.49 | 0.15–1.64 |
| Hepatitis C virus | 3 | 0.79 | 1.19 | 0.30–4.60 | 2 | 0.56 | 0.63 | 0.13–2.99 |
| Alcoholism | 9 | 0.23 | 2.00 | 0.63–6.31 | 15 | 0.99 | - | - |
| NASH | 0 | 0.99 | - | - | 0 | 0.99 | - | - |
| Cryptogenic | 1 | 0.11 | 9.84 | 0.58–166.83 | 0 | 0.99 | - | - |
| Combined cause | 5 | 0.18 | 2.20 | 0.68–7.12 | 6 | 0.07 | 2.74 | 0.89–8.43 |
| Portal hypertension | 12 | 0.35 | 2.06 | 0.43–9.70 | 14 | 0.12 | 5.06 | 0.64–39.98 |
| Hepatocellular carcinoma | 3 | 0.45 | 1.68 | 0.42–6.62 | 4 | 0.17 | 2.37 | 0.67–8.31 |
| Hepatic encephalopathy | 8 | 0.13 | 2.32 | 0.76–7.11 | 12 | 0.002[ | 7.90[ | 2.11–29.51[ |
| History of alcohol consumption | 10 | 0.31 | 1.85 | 0.55–6.23 | 15 | 0.99 | - | - |
| Diabetes mellitus | 3 | 0.25 | 0.46 | 0.12–1.73 | 8 | 0.13 | 2.25 | 0.76–6.64 |
| Hypertension | 4 | 0.36 | 0.57 | 0.17–1.92 | 7 | 0.57 | 1.36 | 0.46–3.99 |
| Previous history of stroke | 1 | 0.20 | 4.88 | 0.41–57.59 | 0 | 0.99 | - | - |
| Renal insufficiency | 1 | 0.44 | 2.40 | 0.25–23.14 | 1 | 0.49 | 2.21 | 0.23–21.21 |
| Coronary artery disease | 0 | 0.99 | - | - | 1 | 0.12 | 9.07 | 0.53–153.14 |
| Hyperlipidemia | 2 | 0.13 | 0.31 | 0.06–1.45 | 5 | 0.96 | 1.02 | 0.32–3.18 |
| Motor and sensory deficit | 1 | 0.93 | 0.91 | 0.10–7.73 | 0 | 0.99 | - | - |
| Motor or sensory deficit | 2 | 0.97 | 1.02 | 0.21–4.97 | 4 | 0.14 | 2.54 | 0.72–8.96 |
statistically significant,
one case had more than one variable.
NASH: non-alcoholic steatohepatitis, OR: odds ratio, CI: confidence interval, n: total number of cases.